Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain
Phase 2
24
about 11 months
18–75
1 site in NC
What this study is about
Researchers are testing whether oxytocin helps reduce pain from heat. Participants will receive oxytocin or a placebo through the nose or vein, and rate their pain levels after each treatment. The trial will last about 329 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Intravenous oxytocin
- 2.Receive Intravenous placebo
- 3.Take Intranasal oxytocin
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
oxytocin (Hormone; causes uterine contractions)
intranasal, infusion
Primary: Pain Scale Score - During Skin Heating, Pain Scale Score - End of 5-minute Skin Heating
Secondary: Pain Scale Score - During Skin Heating